ADVANTAGE PLUS
Report
- Report Number
- 2150060-2019-00048
- Event Type
- Injury
- Date Received
- June 10, 2019
- Date of Event
- May 20, 2019
- Report Date
- June 10, 2019
- Manufacturer
- MEDIVATORS INC.
- Product Code
- FEB
- UDI-DI
- 00677964044755
- PMA / PMN Number
- K102996
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- 003
Narratives
MEDIVATORS SALES REPRESENTATIVE REPORTED A FACILITY USING PROLYSTICA ENZYMATIC INSTRUMENT DETERGENT IN THEIR ADVANTAGE PLUS AUTOMATED ENDOSCOPE REPROCESSOR (AER). PROLYSTICA DETERGENT IS NOT VALIDATED FOR USE WITH THE ADVANTAGE PLUS AER. PER THE AER IFU, ONLY INTERCEPT DETERGENT IS VALIDATED FOR USE IN THE CLEANING CYCLE OF THE AER, THEREFORE THERE IS POTENTIAL THAT THE ENDOSCOPES CLEANED WITH PROLYSTICA DETERGENT WERE NOT ADEQUATELY REPROCESSED. IT IS UNKNOWN HOW LONG THE FACILITY HAS BEEN USING PROLYSTICA WITH THEIR ADVANTAGE PLUS AER. IT WAS REPORTED THAT THE FACILITY OTHERWISE FOLLOWS APPROPRIATE REPROCESSING PROCESSES. MEDIVATORS FIELD SERVICE REPRESENTATIVE INSTRUCTED THE FACILITY TO DISCONTINUE USE OF PROLYSTICA DETERGENT WITH THE ADVANTAGE PLUS AER. THERE HAVE BEEN NO REPORTS OF PATIENT HARM. THIS COMPLAINT WILL CONTINUE TO BE MONITORED IN THE MEDIVATORS COMPLAINT HANDLING SYSTEM.
MEDIVATORS SALES REPRESENTATIVE REPORTED A FACILITY USING PROLYSTICA ENZYMATIC INSTRUMENT DETERGENT IN THEIR ADVANTAGE PLUS AUTOMATED ENDOSCOPE REPROCESSOR (AER). PROLYSTICA DETERGENT IS NOT VALIDATED FOR USE WITH THE ADVANTAGE PLUS AER. PER THE AER IFU, ONLY INTERCEPT DETERGENT IS VALIDATED FOR USE IN THE CLEANING CYCLE OF THE AER, THEREFORE THERE IS POTENTIAL THAT THE ENDOSCOPES CLEANED WITH PROLYSTICA DETERGENT WERE NOT ADEQUATELY REPROCESSED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 479028 | ADVANTAGE PLUS | AUTOMATED ENDOSCOPE REPROCESSOR | FEB | MEDIVATORS INC. | 00677964044755 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |